LEADER 01783oam  2200457 a 450 
001 9910703261103321
005 20120103131344.0
035   $a(CKB)3460000000107085
035   $a(OCoLC)758888859
035   $a(EXLCZ)993460000000107085
100   $a20111027d2011      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 12$aA delicate balance$b[electronic resource] $eFDA and the reform of the medical device approval process : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, April 13, 2011
210  1$aWashington :$cU.S. G.P.O.,$d2011.
215   $a1 online resource (iii, 203 pages) $cillustrations
225 1 $aS. hrg. ;$v112-92
300   $aTitle from title screen (viewed on Oct. 27, 2011).
300   $a"Serial no. 112-4."
320   $aIncludes bibliographical references.
517   $aDelicate balance 
606   $aMedical instruments and apparatus$xEvaluation$xStandards$zUnited States
606   $aMedical instruments and apparatus$xSafety regulations$zUnited States
606   $aPublic health$xStandards$zUnited States
606   $aClinical trials$zUnited States
606   $aProduct safety$xGovernment policy$zUnited States
615  0$aMedical instruments and apparatus$xEvaluation$xStandards
615  0$aMedical instruments and apparatus$xSafety regulations
615  0$aPublic health$xStandards
615  0$aClinical trials
615  0$aProduct safety$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910703261103321
996   $aA delicate balance$93546918
997   $aUNINA